Sagamore Investments
Sagamore Investments is an investment firm established in 2002, headquartered in Beijing, China, with additional offices in Shanghai and Hong Kong. The firm specializes in direct investments as well as fund of funds, focusing on venture capital, growth capital, and late-stage private equity. It primarily targets high-growth sectors aligned with China's consumption upgrade, including fintech, healthcare, artificial intelligence, and education. Sagamore Investments typically seeks to take a majority stake in its direct investments, emphasizing its commitment to fostering growth in these dynamic industries within China.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Cayman Islands
Stealth BioTherapeutics
Convertible Note in 2018
Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies targeting diseases associated with mitochondrial dysfunction. Founded in 2006 and headquartered in George Town, the Cayman Islands, the company’s lead product candidate, Elamipretide, aims to address both rare genetic and common age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide designed to stabilize mitochondrial structure and function under oxidative stress, and SBT-272, which is being evaluated for its potential in treating rare neurodegenerative disorders, including amyotrophic lateral sclerosis. By focusing on mitochondrial health, Stealth BioTherapeutics seeks to improve outcomes for patients suffering from these challenging conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.